Skip to main content
56612 search results for:

Peritoneal Cancer 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 01-05-2024 | Gastric Cancer | OriginalPaper

    Dynamic change in the peritoneal cancer index based on CT after chemotherapy in the overall survival prediction of gastric cancer patients with peritoneal metastasis

    Peritoneal metastasis (PM) is common in metastatic gastric cancer (GC), with an estimated incidence of 55–60% (Cutsem et al. 2016 ; Thomassen et al. 2014 ; Allen et al. 2019 ). PM is the most frequent cause of death in patients with gastric cancer

  2. 03-05-2024 | Cytostatic Therapy | Online First

    Top Peritoneal Surface Malignancy Articles from 2022 to Inform your Cancer Practice

    Over the last few decades, the role of cytoreductive surgery (CRS) with or without regional-based peritoneal therapies such as hyperthermic intraperitoneal chemotherapy (HIPEC) has evolved in the management of patients with peritoneal surface …

  3. 02-03-2024 | Gastric Cancer | OriginalPaper

    Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes

    This retrospective cohort study included adult patients who had primary gastric or Siewert III gastroesophageal junction (GEJ) cancers with PM treated with regional therapy at a National Cancer Institute (NCI)-designated comprehensive cancer

  4. 18-04-2024 | Gastric Cancer | Online First

    Dual-energy CT quantitative parameters to evaluate occult peritoneal metastasis in advanced gastric cancer preoperatively

    Gastric cancer (GC) is the fifth most common cancer and ranks fourth in cancer related mortality globally [ 1 ]. Peritoneal metastasis (PM) from GC can be diagnosed with the incidence of as high as 40% through a staging laparoscopy, and is …

  5. 18-04-2024 | Online First

    ASO Visual Abstract: Initial Experience with Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis—Safety and Outcomes

  6. 19-03-2024 | Colorectal Cancer | OriginalPaper

    Stenting as bridge to surgery versus upfront emergency resection for non-metastatic left sided obstructing colorectal cancer: risk of peritoneal recurrence and long-term outcomes

    Colorectal cancer (CRC) is the second most prevalent cancer worldwide [ 1 ], with approximately 20% presenting as acute obstruction [ 2 , 3 ]. Obstruction confers worse oncological outcome and emergency surgery is associated with higher morbidity …

  7. Open Access 12-04-2024 | Cytostatic Therapy | Online First

    Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer

    Chemotherapy drugs efficiently eradicate rapidly dividing differentiated cells by inducing cell death, but poorly target slowly dividing cells, including cancer stem cells and dormant cancer cells, in the later course of treatment. Prolonged …

  8. Open Access 28-03-2024 | Metastasis | Online First

    Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination

    Epithelial ovarian cancer (EOC) is often diagnosed in advanced stage with peritoneal dissemination. Recent studies indicate that aberrant accumulation of collagen fibers in tumor stroma has a variety of effects on tumor progression. We refer to …

  9. 24-01-2024 | Tuberculosis | OriginalPaper

    Coexistence of ovarian cancer and peritoneal tuberculosis: a case report

    Peritoneal tuberculosis (TB) is known to mimic advanced ovarian cancer. In this case report, we describe a unique case of ovarian cancer (endometrioid carcinoma grade 3) at the International Federation of Gynecology and Obstetrics (FIGO) stage IC1 …

  10. Open Access 09-03-2024 | Ascites | OriginalPaper

    Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis

    Peritoneal metastasis (PM), a fatal type of fatal metastasis, can develop in over 15% of patients with gastric cancer (GC) [ 1 ]. However, chemotherapies and targeted therapies have failed to prevent GC with peritoneal carcinomatosis (PM-GC) onset …

  11. 16-03-2024 | Gastric Cancer | Erratum

    Correction: Single-cell RNA sequencing reveals the lineage of malignant epithelial cells and upregulation of TAGLN2 promotes peritoneal metastasis in gastric cancer

  12. 25-03-2024 | Peritoneal Cancer | Online First

    The Potential Prognostic Impact of Associated Peritoneal Carcinomatosis in Patients with Stage II and III Epithelial Ovarian Cancer Who Had Upfront Complete Cytoreduction

    The presence of metastatic peritoneal nodules in epithelial ovarian cancer (EOC) is defined as stage II (in case of pelvic peritoneal nodules) or stage III (in case of abdominal peritoneal nodules). Furthermore, as FIGO staging system is used for …

  13. 21-03-2024 | Gastric Cancer | Online First

    Macroscopic type is implicated in the prognostic impact of initial chemotherapy on peritoneal lavage cytology-positive gastric cancer with no other noncurative factors

    Positive peritoneal lavage cytology (CY1) in gastric cancer (GC) indicates the presence of free cancer cells in the peritoneal cavity and is defined as distant metastasis (M1) [ 1 – 3 ]. CY1 is a factor that negatively affects overall survival (OS) …

  14. 29-01-2024 | Gastrectomy | Letter

    Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer

    Details of this single-arm, intra-institutional phase 2 clinical trial (NCT02891447) have been previously reported. 2 The eligibility criteria specified patients who had gastric or gastroesophageal adenocarcinoma with histologic confirmation of …

  15. Open Access 01-12-2024 | Cholangiocarcinoma | OriginalPaper

    Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer

    Biliary tract cancer (BTC) is an aggressive tumor, and most patients exhibit advanced disease at presentation [ 1 ]. The incidence of cholangiocarcinoma has increased progressively worldwide over the past few decades [ 2 – 5 ], and surgical …

  16. 31-01-2024 | Metastasis | OriginalPaper

    A case of metachronous oligo-hepatic and peritoneal metastases of pancreatic cancer with a favorable outcome after conversion surgery combined with perioperative sequential chemotherapy

    Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies, and the prognosis for its recurrence after surgery is very poor. Here, we report a case of metachronous oligo-hepatic and peritoneal metastases in a patient who …

  17. Open Access 01-12-2024 | Peritoneal Cancer | OriginalPaper

    Optimal peritoneal cancer index cutoff point for predicting surgical resectability of pseudomyxoma peritonei in treatment-naive patients

    Pseudomyxoma peritonei (PMP) is a rare malignant disease mainly originated from appendiceal mucinous tumors, which often produced mucinous and gelatinous masses [ 1 ]. The clinical presentation of PMP varies widely and depends on the disease …

  18. 23-02-2024 | Metastasis | Online First

    Conversion therapy with pembrolizumab for a peritoneal metastasis of rectal cancer causing hydronephrosis in a patient with Lynch syndrome

    A 44-year-old woman with Lynch syndrome was referred to our hospital for treatment of recurrence of microsatellite instability-high rectal cancer. [18F]Fluorodeoxyglucose (18FDG)-positron emission tomography revealed a peritoneal metastasis with …

  19. Open Access 13-01-2024 | Lymphadenectomy | OriginalPaper

    Peritoneal mesometrial resection with lymphadenectomy following prior hysterectomy in intermediate/high-risk endometrial cancer: feasibility and safety

    With around 11.090 newly diagnosed patients per year (forecast for 2020: 10600), endometrial cancer (EC) is the 4th most common cancer in women in developed countries and the most common female genital cancer entity in Germany [ 1 , 2 ]. In Korea …

  20. Open Access 26-01-2024 | Peritoneal Cancer | Online First

    Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease

    Gastric cancer (GC) is the fifth most common cancer and fourth leading cause of cancer deaths worldwide in 2020 [ 1 ]. In the USA, an estimated 26,500 new gastric cancer cases will be diagnosed and 11,130 people will die due to this cancer in 2023 …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.